Westchester Capital Management, Inc. Pfizer Inc Transaction History

Westchester Capital Management, Inc.

$411 Million
Q3 2024

A detailed history of Westchester Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Westchester Capital Management, Inc. holds 278,553 shares of PFE stock, worth $7.36 Million. This represents 1.96% of its overall portfolio holdings.

Number of Shares

278,553

Previous 278,316 0.09%

Holding current value

$7.36 Million

Previous $7.79 Million 3.52%

% of portfolio

1.96%

Previous 1.97%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$27.7 - $31.39 $6,564 - $7,439	237 Added 0.09%	278,553 $8.06 Million
Q2 2024 Jul 26, 2024	SELL	$25.26 - $29.6 $54,207 - $63,521	-2,146 Reduced 0.77%	278,316 $7.79 Million
Q1 2024 May 03, 2024	SELL	$25.89 - $29.73 $61,074 - $70,133	-2,359 Reduced 0.83%	280,462 $7.78 Million
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $72,223 - $93,810	-2,764 Reduced 0.97%	282,821 $8.14 Million
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $67,902 - $79,371	2,116 Added 0.75%	285,585 $9.47 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $42,115 - $48,727	1,166 Added 0.41%	283,469 $10.4 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $46,874 - $61,023	1,190 Added 0.42%	282,303 $11.5 Million
Q4 2022 Feb 08, 2023	SELL	$41.75 - $54.5 $127,003 - $165,789	-3,042 Reduced 1.07%	281,113 $14.4 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $27,437 - $33,494	-627 Reduced 0.22%	284,155 $12.4 Million
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $20,845 - $24,716	-448 Reduced 0.16%	284,782 $14.9 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $52,338 - $64,853	-1,144 Reduced 0.4%	285,230 $14.8 Million
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $173,915 - $257,801	-4,209 Reduced 1.45%	286,374 $16.9 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $38,504 - $49,462	981 Added 0.34%	290,583 $12.5 Million
Q2 2021 Aug 04, 2021	BUY	$35.91 - $40.68 $61,657 - $69,847	1,717 Added 0.6%	289,602 $11.3 Million
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $14,501 - $16,354	-433 Reduced 0.15%	287,885 $10.4 Million
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $136,289 - $173,304	4,072 Added 1.43%	288,318 $10.6 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $1.68 Million - $1.97 Million	52,805 Added 22.82%	284,246 $10.4 Million
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $85,842 - $104,139	-2,850 Reduced 1.22%	231,441 $7.57 Million
Q1 2020 May 01, 2020	BUY	$27.03 - $38.62 $182,587 - $260,878	6,755 Added 2.97%	234,291 $7.65 Million
Q4 2019 Feb 05, 2020	BUY	$32.92 - $37.36 $677,559 - $768,943	20,582 Added 9.95%	227,536 $8.92 Million
Q3 2019 Nov 05, 2019	BUY	$32.49 - $42.13 $346,538 - $449,358	10,666 Added 5.43%	206,954 $7.44 Million
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $251,390 - $282,252	6,798 Added 3.59%	196,288 $8.5 Million
Q1 2019 May 07, 2019	SELL	$37.5 - $41.2 $25,125 - $27,604	-670 Reduced 0.35%	189,490 $8.05 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $325,456 - $371,055	-8,460 Reduced 4.26%	190,160 $8.3 Million
Q3 2018 Nov 06, 2018	SELL	$34.47 - $41.81 $42,570 - $51,635	-1,235 Reduced 0.62%	198,620 $8.75 Million
Q2 2018 Aug 01, 2018	SELL	$32.98 - $35.16 $64,278 - $68,526	-1,949 Reduced 0.97%	199,855 $7.25 Million
Q1 2018 May 04, 2018	SELL	$31.91 - $37.02 $141,808 - $164,516	-4,444 Reduced 2.15%	201,804 $7.16 Million
Q4 2017 Feb 02, 2018	BUY	$33.26 - $35.29 $56,209 - $59,640	1,690 Added 0.83%	206,248 $7.47 Million
Q3 2017 Oct 26, 2017	BUY	$31.0 - $34.15 $6.34 Million - $6.99 Million	204,558	204,558 $7.3 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westchester Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westchester Capital Management, Inc. with notifications on news.

Account

Westchester Capital Management, Inc. Pfizer Inc Transaction History